Compare Linde PLC (LIN) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Linde PLC vs Koninklijke Philips NV — how do they compare? Linde PLC trades at $483.73 (market cap $222.05B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Linde PLC is far larger — about 9.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Linde PLC for 88 Days and Koninklijke Philips NV for 84 Days on average.
| LIN | PHG | |
|---|---|---|
Market Cap | $222.05B | $23.52B |
Volume | 2,116,440 | 1,635,069 |
Sector | Basic Materials | Health |
52-Week High | $546.64 | $32.91 |
52-Week Low | $389.38 | $23.81 |
Typical Hold Time | 88 Days | 84 Days |
Enterprise Value | $245.17B | $29.87B |
Dividend Yield | 1.33% | 4.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Linde (LIN) trades at $481.70, down 0.47% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $4.50 beating estimates of $4.49, and maintains healthy profitability with a 20.43% net income margin. Analyst sentiment remains overwhelmingly positive with 89.66% buy ratings and a $557.10 consensus price target representing 15.6% upside potential from current levels.
The outlook remains favorable given Linde's leadership in industrial gases and exposure to AI chip manufacturing growth, though valuation at 31.08 P/E requires continued execution. Key risks include margin pressure from higher capital expenditures and competitive dynamics in the electronics sector. The stock's technical setup suggests support near $479 with resistance at $485, providing clear levels for near-term price action.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite three consecutive quarterly earnings beats. The company shows improving fundamentals with net income turning positive at $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care.
While analyst consensus leans Hold (63.64%), the improving profitability trajectory and reasonable valuation (P/E 18.94) present opportunity, though technical weakness and competitive healthcare market risks require monitoring. The stock faces resistance near $25 with support at $24, with institutional ownership showing mixed signals through recent acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
